Exicure
X
Allergan bolsters aesthetics pipeline with Exicure hair loss deal
https://pharmaphorum.com/news/allergan-bolsters-aesthetics-unit-with-exicure-hair-loss-deal/
Exicure lists on Nasdaq, raising $55m for cancer, neurology push
Phil Taylor
Exicure, immuno-oncology, rna therapeutics, solid tumour
0 Comment
X
Exicure lists on Nasdaq, raising $55m for cancer, neurology push
https://pharmaphorum.com/news/exicure-lists-on-nasdaq-raising-55m-for-cancer-neurology-push/